ВЛИЯНИЕ ГЛУТАМАТА НАТРИЯ НА МАССУ ТЕЛА И РАЗВИТИЕ ОЖИРЕНИЯ (ОБЗОР ЛИТЕРАТУРЫ)

Гордиенко Л. П.

ОБЗОРЫ ЛИТЕРАТУРЫ

Научная статья.

Ожирение является глобальной проблемой современного общества и приобретает разме-ры пандемии. Прогрессивное увеличение количества пациентов с ожирением характеризуется различ-ными негативными тенденциями медицинского, демографического и экономического характера. Стре-мительное увеличение распространенности ожирения обусловлено так называемой «вестернизацией» общества, что сказалось на изменении образа жизни человечества со снижением уровня физической активности и увеличением потребления высококалорийных продуктов, а также широким использованием в пищевой промышленности пищевых добавок, прежде всего глутамата натрия. В работе проанализиро-ваны данные научных работ о влиянии глутамата натрия на массу тела и развитие ожирения у животных и человека.

пищевые добавки, глутамат натрия, ожирение

1. Vorobev V.V. Vrednoe vozdeystvie pischevyih dobavok na bezopasnost moreproduktov i zdorove naseleniya / V.V. Vorobev //
Ryibnoe hozyaystvo. – 2008. – № 5. – S. 8-11.
2. Hordiienko L.P. Mehanizmi rozvitku patologIchnih zmin u slinnih zalozah schuriv za umov eksperimentalnogo ozhirinnya: avtoref.
dis. na zdobuttya nauk. stupenya kand. med. nauk: spets. 14.03.04 “Patologichna fiziologiya” / L.P. Hordiienko. – Zaporizhzhya,
2016. – 23 s.
3. Kosyigina A.V. Novoe v patogeneze ozhireniya: adipokinyi – gormonyi zhirovoy tkani / A.V. Kosyigina, O.V. Vasyukova // Problemyi
endokrinologii. – 2009. – T. 55, № 1. – S. 44-50.
4. Pasieshvili L.M. Imunniy disbalans yak pidgruntya progresuvannya steatogepatitu u hvorih na arterialnu gipertenzIyu ta ozhirInnya
/ L.M. Pasieshvili, T.F. HoroshavIna // Ukrayinskiy terapevtichniy zhurnal. – 2014. – № 2. – S. 40-44.
5. Patofiziologichna harakteristika eksperimentalnoyi modeli ozhirinnya u samits schurIv, viklikanoyi neonatalnim vvedennyam glutamatu
natriyu / V.V. Konopelnyuk, I.Yu. Pribitko, O.I. Tsiryuk [ta in.] // Science Rise: Biological Science. – 2016. – T. 3, № – S. 14-18.
6. Rutska A.V. Toksichniy vpliv glutamatu natriyu na zhiviy organizm (oglyad literaturi) / A.V. Rutska, N.V. Getsko, I.Ya. Krinitska //
Medichna ta klinichna himIya. – 2017. – T. 19, № 1. – S. 119-127.
7. Sarafanova L.A. Pischevyie dobavki: Entsiklopediya. – 2-e izd. / L.A. Sarafanova. – SPb: GIORD, 2004. – 808 s.

8. Svistilnik T.V. Fenomen eksaytotoksichnosti. Mehanizmi viniknennya, znachennya v rozvitku neyronalnogo poshkodzhennya
ta mozhlivosti yogo korektsiyi pri patologiyah TsNS / T.V. Svistilnik // Biomedical and biosocial anthropology. – 2012. – № 1. –
S. 207-215.
9. Falaleeva T.M. Vpliv trivalogo vvedennya glutamatu natriyu na strukturno-funktsionalniy stan shlunka ta massu tila schuriv /
T.M. Falaleeva, V.M. Kuharskiy, T.V. Beregova // FizIiologichniy zhurnal. – 2010. – T. 56, № 4. – S. 102-110.
10. Falaleeva T.M. Zmini masi tila schuriv za umov dovgotrivalogo vvedennya glutamatu natriyu / T.M. Falaleeva // Svit meditsini ta
biologiyi. – 2012. – № 2. – S. 170-172.
11. Acquired flavor acceptance and intake facilitated by monosodium glutamate in humans / M.R. Yeomans, N.J. Gould, S. Mobini [et
al.] // Physiol Behav.– 2008. – Vol. 93, № 4-5. – P. 958-966.
12. Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study / K. He, L. Zhao,
M.L. Daviglus [et al.] // Obesity. – 2008. – Vol. 16, № 8. – P. 1875-1880.
13. Effect of food restriction on energy expenditure of monosodium glutamate-induced obese rats / J. Luz, V.P. Pasin, D.J. Silva [et al.]
// Nutr. Metab. – 2010. – Vol. 56, № 1. – P. 31-35.
14. Effect of treatment with MSG on growth, satiety and epididymal adiposity in neonatal rats / L.C. Lemos, J.A. Pochapski,
A. Raczenski [et al.] // Journal of Applied Pharmaceutical Science. – 2013. – Vol. 3, № 1. – P. 21-25.
15. Epidemiological studies of monosodium glutamate and health / H. VuThiThu, A. Wakita, S. Shikanai [et al.] // J Nutr Food Sci. –
2013. – Vol. 10. – P. 1-4.
16. Glutamate-induced obesity leads to decreased sperm reserves and acceleration of transit time in the epididymis of adult male rats
/ G.S. Fernandes, A.C. Arena, K.E. Campos [et al.] // Reproductive Biology and Endocrinology. – 2012. – Vol. 10, № 105. – P. 1-6.
17. Hermanussen M. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite / M. Hermanussen,
A.P. Garsia, M. Sunder // Eur J ClinNutr. – 2006. – Vol. 60, № 1. – P. 25-31.
18. Hermanussen M. Overweight, appetite control, and the role of glutamate and excess nutritional protein during child development
/ M. Hermanussen, J.F. Tresguerres // Hum ontogenet. – 2007. – Vol. 1, № 1. – P. 23-35.
19. Husarova V. Monosodium Glutamate toxic effects and their implications for human intake: A review / V. Husarova, D. Ostatnikova
// JMED Research. – 2013. – Vol. 2013. – P. 1-12.
20. Insawang T. Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai
population / T. Insawang, C. Selmi, U. Cha’on // NutrMetab (Lond). – 2012. – Vol. 1, № 9. – P. 50-52.
21. Interactive effects of neonatal exposure to monosodium glutamate and aspartame on glucose homeostasis / K.S. Collison,
N.J. Makhoul, M.Z. Zaidi [et al.] // Nutrition & Metabolism. – 2012. – Vol. 9. – P. 1-14.
22. Monosodium glutamate neonatal intoxication associated with obesity in adult Stage is characterized by chronic inflammation
and increased mRNA expression of peroxisome proliferator-activated receptors in mice / R. Roman-Ramos, J.C. Almanza-Perez,
R. Garcia-Macedo [et al.] // Basic & Clinical Pharmacology & Toxicology. – 2011. – Vol. 108, № 6. – P. 406-413.
23. Monosodium glutamate raises antral distension and plasma amino acid after a standard meal in humans / B. Boutry, H. Matsumoto,
G. Airinei [et al.] // Am J Physiol Gastrointest Liver Physiol.– 2011. – Vol. 300, № 1. – P. 137-145.
24. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing
meal / H. Hosaka, M. Kusano, H. Zai [et al.] // Aliment Pharmacol Ther. – 2012. – Vol. 36. – P. 895-903.
25. Samuels A. Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: findings
from the Jiangsu Nutrition Study of Chinese adults – comments by Samuels / A. Samuels // Br. J Nutr. – 2010. – Vol. 9. – P. 11-13.
26. Sensitivity to food additives, vasoactive amines and salicylates: a review of the evidence / I.J. Skypala, M. Williams, L. Reeves [et
al.] // Clin Transl Allergy. – 2015. – Vol. 5, № 34. – P. 1-11.
27. Tarasoff L. Monosodium L-glutamate: A double-blind study and review / L. Tarasoff, M.F. Kelly // Food and Chemical Toxicol. –
1993. – Vol. 31. – P. 1019-1035.
28. The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut
hormone and GLP-1 receptor interaction / M. Shannon, B. Green, G. Willars[et al.] // Toxicol Lett.– 2017. – Vol. 265. – P. 97-105.
29. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate / M. Nagata, W. Suzuki, S. Iizuka [et al.] // Exp.
Anim. – 2006. – Vol. 55, № 2. – P. 109-115.
30. Von Diemen V. Experimental model to induce obesity in rats / V. Von Diemen, E.N. Trindade, M.R. Trindade // Acta Cir Bras. – 2006.
– Vol. 21, № 6. – P. 425-429.
31. WHO fact sheet № 311, jan. 2015. – Available from URL: http: // www.who.int/mediacentre/factsheets/fs311/en/.
32. Zhao J. Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats / J. Zhao, J. Yang,
H. Gregersen // Diabetologia. – 2003. – Vol. 46, № 12. – P. 1688-1697.

«Вестник проблем биологии и медицины» Выпуск 4 Том 3 (141), 2017 год, 33-37 страницы, код УДК 616-056.5:612.393(-035.8)

10.29254/2077–4214–2017–4–3–141–33-37